About
About FACIT
Our Network
Leadership
Careers
Contact
Portfolio
Funds
Funds & Programs Overview
Prospects
Compass Rose
WeSEED
Falcons’ Fortunes
2026 Event Info & RSVP
Pitch Competition – apply
News
Search:
Contrast:
Normal
Contrast Setting
High
Text Size:
Portfolio Category:
Compass Rose
FACIT-28 | Fusion Pharmaceuticals Inc. (acquired by AstraZeneca)
October 5, 2021
–
FACIT-07 | Profound Medical
October 5, 2021
–
FACIT-29 | Novera Therapeutics Inc.
October 5, 2021
–
FACIT-08 | UHN (proteosome inhibitor, Dr. A. Schimmer)
October 5, 2021
–
FACIT-31 | Propellon Therapeutics Inc.
October 5, 2021
–
FACIT-09 | Sunnybrook Research Institute (Glypican-3, Dr. J. Filmus)
October 5, 2021
–
FACIT-10 | UHN (radiofrequency ablation, Dr. M. Sherar)
October 5, 2021
–
Posts navigation
«
1
2
3
4
recaptcha